# Phase 1 Study of DHP2302R1 and DHP2302R2 in Healthy Adult Volunteers

> **NCT06318845** · PHASE1 · COMPLETED · sponsor: **Daehwa Pharmaceutical Co., Ltd.** · enrollment: 42 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** DHP2302R1
- **DRUG:** DHP2302R2

## Key facts

- **NCT ID:** NCT06318845
- **Lead sponsor:** Daehwa Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-04
- **Primary completion:** 2024-04-26
- **Final completion:** 2024-05-07
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2024-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06318845

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06318845, "Phase 1 Study of DHP2302R1 and DHP2302R2 in Healthy Adult Volunteers". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06318845. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*